LEXX LEXARIA BIOSCIENCE CORP revenue, earnings and financials
For the quarter ended May 31, 2026, LEXARIA BIOSCIENCE CORP reported revenue of $0 (down 100.0% from a year earlier), net income of −$1.99M and diluted EPS of −$0.08; over the last four quarters revenue was $194K and net income −$7.73M; for the fiscal year ended August 2025 revenue was $706K, up 52.0% on the year before.
LEXX annual revenue and earnings
- Fiscal year ended Aug 2025: revenue $706K, gross profit $703K, operating income −$11.9M, net income −$11.9M (margin -1686.0%), EPS −$0.66
- Fiscal year ended Aug 2024: revenue $464K, gross profit $459K, operating income −$5.75M, net income −$5.80M (margin -1248.2%), EPS −$0.47
- Fiscal year ended Aug 2023: revenue $226K, gross profit $195K, operating income −$6.53M, net income −$6.66M (margin -2946.4%), EPS −$1.01
- Fiscal year ended Aug 2022: revenue $255K, gross profit $184K, operating income −$6.62M, net income −$7.27M (margin -2846.3%), EPS n/a
- Fiscal year ended Aug 2021: revenue $723K, gross profit $547K, operating income −$5.69M, net income −$4.03M (margin -557.2%), EPS −$0.95
LEXX quarterly revenue and earnings
- Quarter ended May 31, 2026: revenue $0 (down 100.0% year over year), net income −$1.99M, EPS −$0.08
- Quarter ended Feb 28, 2026: revenue $20.0K (down 88.5% year over year), net income −$1.45M, EPS −$0.06
- Quarter ended Nov 30, 2025: revenue $0 (down 100.0% year over year), net income −$1.60M, EPS −$0.07
- Quarter ended Aug 31, 2025 (from the annual report): revenue $174K (up 107.1% year over year), net income −$2.70M, EPS −$0.14
- Quarter ended May 31, 2025: revenue $174K (up 107.1% year over year), net income −$3.79M, EPS −$0.21
- Quarter ended Feb 28, 2025: revenue $174K (up 20.0% year over year), net income −$2.71M, EPS −$0.15
- Quarter ended Nov 30, 2024: revenue $184K (up 21.6% year over year), net income −$2.70M, EPS −$0.16
- Quarter ended Aug 31, 2024 (from the annual report): revenue $84.0K (up 173.3% year over year), net income −$2.18M, EPS −$0.15
- Quarter ended May 31, 2024: revenue $84.0K (up 8.1% year over year), net income −$1.78M, EPS −$0.13
- Quarter ended Feb 29, 2024: revenue $145K (up 624.1% year over year), net income −$650K, EPS −$0.06
- Quarter ended Nov 30, 2023: revenue $151K (up 54.8% year over year), net income −$1.18M, EPS −$0.13
- Quarter ended Aug 31, 2023 (from the annual report): revenue $30.7K (down 72.3% year over year), net income −$1.24M, EPS n/a
- Quarter ended May 31, 2023: revenue $77.7K (down 22.1% year over year), net income −$2.37M, EPS n/a
- Quarter ended Feb 28, 2023: revenue $20.0K (down 34.7% year over year), net income −$1.30M, EPS n/a
- Quarter ended Nov 30, 2022: revenue $97.7K (up 604.1% year over year), net income −$1.76M, EPS n/a
- Quarter ended Aug 31, 2022 (from the annual report): revenue $111K, net income −$1.47M, EPS n/a
- Quarter ended May 31, 2022: revenue $99.7K (down 51.1% year over year), net income −$2.38M, EPS n/a
- Quarter ended Feb 28, 2022: revenue $30.7K (down 84.0% year over year), net income −$1.43M, EPS −$0.25
- Quarter ended Nov 30, 2021: revenue $13.9K, net income −$1.99M, EPS −$0.35
- Quarter ended Aug 31, 2021: revenue n/a, net income −$1.18M, EPS n/a
LEXX cash flow, buybacks and dividends
- Fiscal year ended Aug 2025: operating cash flow −$10.5M, share buybacks n/a
- Fiscal year ended Aug 2024: operating cash flow −$4.96M, share buybacks n/a
- Fiscal year ended Aug 2023: operating cash flow −$5.88M, share buybacks n/a
- Fiscal year ended Aug 2022: operating cash flow −$4.88M, share buybacks n/a
- Fiscal year ended Aug 2021: operating cash flow −$3.99M, share buybacks n/a
LEXX balance sheet
- May 31, 2026: cash $3.50M, total assets $4.78M, total liabilities $437K, shareholders' equity $4.74M
- Feb 28, 2026: cash $5.10M, total assets $6.49M, total liabilities $277K, shareholders' equity $6.60M
- Nov 30, 2025: cash $4.30M, total assets $6.05M, total liabilities $1.53M, shareholders' equity $4.91M
- Aug 31, 2025: cash n/a, total assets $4.18M, total liabilities $1.57M, shareholders' equity $2.99M
- May 31, 2025: cash $4.60M, total assets $6.74M, total liabilities $1.57M, shareholders' equity $5.55M
- Feb 28, 2025: cash $6.50M, total assets $8.68M, total liabilities $1.92M, shareholders' equity $7.14M
- Nov 30, 2024: cash n/a, total assets $9.79M, total liabilities $400K, shareholders' equity $9.77M
- Aug 31, 2024: cash n/a, total assets $8.87M, total liabilities $1.21M, shareholders' equity $8.04M
What is LEXX's revenue?
LEXARIA BIOSCIENCE CORP reported $194K of revenue over its last four quarters, through May 31, 2026.
Is LEXX profitable?
No. LEXARIA BIOSCIENCE CORP lost $7.73M over the last four quarters.
What is LEXX's EPS?
Diluted earnings per share over the last four quarters were −$0.35; −$0.08 in the latest quarter.